Centessa Pharmaceuticals (CNTA) Short Interest Ratio & Short Volume $16.17 +0.03 (+0.19%) (As of 09:46 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Centessa Pharmaceuticals Short Interest DataCentessa Pharmaceuticals (CNTA) has a short interest of 2.01 million shares, representing 2.51% of the float (the number of shares available for trading by the public). This marks a 2.55% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.4, indicating that it would take 3.4 days of the average trading volume of 389,349 shares to cover all short positions.Current Short Interest2,010,000 sharesPrevious Short Interest1,960,000 sharesChange Vs. Previous Month+2.55%Dollar Volume Sold Short$32.34 millionShort Interest Ratio3.4 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares113,310,000 sharesFloat Size79,980,000 sharesShort Percent of Float2.51%Today's Trading Volume2,843 sharesAverage Trading Volume389,349 sharesToday's Volume Vs. Average1% Short Selling Centessa Pharmaceuticals? Sign up to receive the latest short interest report for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNTA Short Interest Over TimeCNTA Days to Cover Over TimeCNTA Percentage of Float Shorted Over Time Ad WealthPressCould TSLA reach $500 a share? Free ebook says it’s possible.Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link Centessa Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20242,010,000 shares $32.34 million +2.6%2.5%3.4 $16.09 9/30/20241,960,000 shares $31.34 million +30.7%2.5%3.3 $15.99 9/15/20241,500,000 shares $25.49 million -23.9%2.0%2.8 $16.99 8/31/20241,970,000 shares $26.60 million +79.1%2.6%4.7 $13.50 8/15/20241,100,000 shares $14.40 million -20.3%1.5%3.7 $13.09 7/31/20241,380,000 shares $14.53 million -4.8%2.0%6 $10.53 Get the Latest News and Ratings for CNTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Centessa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/20241,450,000 shares $13.83 million +27.2%2.1%5.9 $9.54 6/30/20241,140,000 shares $10.29 million +7.6%1.7%5 $9.03 6/15/20241,060,000 shares $10.79 million -15.2%1.6%4.9 $10.18 5/31/20241,250,000 shares $10.79 million -29.0%2.0%6 $8.63 5/15/20241,760,000 shares $15.47 million -1.7%2.9%8.2 $8.79 4/30/20241,790,000 shares $16.40 million +39.8%3.0%5.3 $9.16 4/15/20241,280,000 shares $13.80 million -26.4%2.1%3 $10.78 3/31/20241,740,000 shares $19.66 million +13.0%3.1%4.4 $11.30 3/15/20241,540,000 shares $16.56 million No Change2.8%3.9 $10.75 2/29/20241,540,000 shares $16.19 million -3.1%2.8%4.2 $10.51 2/15/20241,590,000 shares $17.22 million +43.2%2.9%4.2 $10.83 1/31/20241,110,000 shares $9.09 million -11.2%1.9%4.5 $8.19 1/15/20241,250,000 shares $8.88 million +14.7%2.2%7.4 $7.10 12/31/20231,090,000 shares $8.68 million -42.3%1.9%6.9 $7.96 12/15/20231,890,000 shares $13.44 million +11.2%3.2%12.8 $7.11 11/30/20231,700,000 shares $10.20 million +11.1%2.9%12.2 $6.00 11/15/20231,530,000 shares $11.03 million +15.0%2.6%14 $7.21 10/31/20231,330,000 shares $8.74 million -2.9%2.3%11.9 $6.57 10/15/20231,370,000 shares $8.23 million +1.5%2.4%11.2 $6.01 9/30/20231,350,000 shares $8.73 million +0.8%2.3%9.4 $6.47 9/15/20231,340,000 shares $9.33 million +3.1%2.3%9.2 $6.96 8/31/20231,300,000 shares $9.80 million -29.7%2.3%8 $7.54 8/15/20231,850,000 shares $12.78 million -0.5%3.2%10.9 $6.91 7/31/20231,860,000 shares $14.69 million +2.2%3.3%10.1 $7.90 7/15/20231,820,000 shares $13.78 million +1.1%3.3%13 $7.57 6/30/20231,800,000 shares $11.14 million +2.9%3.9%11.7 $6.19 6/15/20231,750,000 shares $9.52 million -1.7%3.8%11 $5.44 5/31/20231,780,000 shares $8.03 million +4.7%3.9%12 $4.51 5/15/20231,700,000 shares $7.89 million -2.3%3.7%9.4 $4.64 4/30/20231,740,000 shares $8.21 million No Change3.8%10.7 $4.72 4/15/20231,740,000 shares $6.99 million -10.3%3.8%9.2 $4.02 3/31/20231,940,000 shares $7.47 million +6.6%4.3%10.9 $3.85 3/15/20231,820,000 shares $7.04 million -1.1%4.0%11.3 $3.87 2/28/20231,840,000 shares $6.48 million +1.7%4.1%12.4 $3.52Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide 2/15/20231,810,000 shares $5.72 million -0.6%4.0%13.5 $3.16 1/31/20231,820,000 shares $7.28 million +0.6%4.0%16 $4.00 1/15/20231,810,000 shares $6.70 million +2.3%4.0%15.7 $3.70 12/30/20221,770,000 shares $5.49 million -4.8%3.9%16.7 $3.10 12/15/20221,860,000 shares $6.55 million -8.8%4.1%16.4 $3.52 11/30/20222,040,000 shares $8.16 million -5.6%4.5%14.8 $4.00 11/15/20222,160,000 shares $7.62 million -3.1%4.8%12.7 $3.53 10/31/20222,230,000 shares $8.85 million +4.7%5.0%12.9 $3.97 10/15/20222,130,000 shares $8.54 million +3.9%4.7%11.8 $4.01 9/30/20222,050,000 shares $8.24 million -22.9%4.6%12.4 $4.02 9/15/20222,660,000 shares $12.64 million -6.3%5.9%17.1 $4.75 8/31/20222,840,000 shares $12.35 million +4.8%6.4%19.5 $4.35 8/15/20222,710,000 shares $10.54 million -3.2%6.1%10 $3.89 7/31/20222,800,000 shares $12.10 million No Change6.4%9.5 $4.32 7/15/20222,800,000 shares $14.59 million -1.8%6.4%9.4 $5.21 6/30/20222,850,000 shares $13.88 million +4.0%6.5%9.7 $4.87 6/15/20222,740,000 shares $11.67 million -20.8%6.2%8.9 $4.26 5/31/20223,460,000 shares $15.57 million -5.0%7.9%11.5 $4.50 5/15/20223,640,000 shares $19.66 million +3.1%8.3%21.8 $5.40 4/30/20223,530,000 shares $30.78 million +4.4%8.0%24.5 $8.72 4/15/20223,380,000 shares $30.08 million -1.5%7.7%22.7 $8.90 3/31/20223,430,000 shares $30.77 million -0.6%7.8%20 $8.97 3/15/20223,450,000 shares $27.05 million -1.4%8.2%22.3 $7.84 2/28/20223,500,000 shares $31.22 million +6.1%8.3%20.6 $8.92 2/15/20223,300,000 shares $33.66 million +2.5%7.9%18 $10.20 1/31/20223,220,000 shares $30.69 million +17.1%6.2%17.3 $9.53 1/15/20222,750,000 shares $24.50 million +24.4%4.9%13.4 $8.91 12/31/20212,210,000 shares $24.88 million +7.3%4.0%10.2 $11.26 12/15/20212,060,000 shares $22.70 million -1.9%3.7%9.4 $11.02 11/30/20212,100,000 shares $24.89 million +6.6%3.8%9.6 $11.85 11/15/20211,970,000 shares $23.48 million +26.3%3.5%10.2 $11.92 10/29/20211,560,000 shares $26.83 million -3.1%2.4%9 $17.20 10/15/20211,610,000 shares $27.05 million +36.4%2.5%10.1 $16.80 9/30/20211,180,000 shares $19.71 million +38.1%1.9%7.6 $16.70 9/15/2021854,400 shares $17.78 million +9.1%1.3%5.5 $20.81 8/31/2021783,300 shares $17.27 million -0.6%1.2%4.5 $22.05 8/13/2021787,800 shares $16.06 million No Change1.3%2.9 $20.38 CNTA Short Interest - Frequently Asked Questions What is Centessa Pharmaceuticals' current short interest? Short interest is the volume of Centessa Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 2,010,000 shares of CNTA short. 2.51% of Centessa Pharmaceuticals' shares are currently sold short. Learn More on Centessa Pharmaceuticals' current short interest. What is a good short interest ratio for Centessa Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNTA shares currently have a short interest ratio of 3.0. Learn More on Centessa Pharmaceuticals's short interest ratio. What is a good short interest percentage for Centessa Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.51% of Centessa Pharmaceuticals' floating shares are currently sold short. Is Centessa Pharmaceuticals' short interest increasing or decreasing? Centessa Pharmaceuticals saw a increase in short interest in October. As of October 15th, there was short interest totaling 2,010,000 shares, an increase of 2.6% from the previous total of 1,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Centessa Pharmaceuticals' float size? Centessa Pharmaceuticals currently has issued a total of 113,310,000 shares. Some of Centessa Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Centessa Pharmaceuticals currently has a public float of 79,980,000 shares. How does Centessa Pharmaceuticals' short interest compare to its competitors? 2.51% of Centessa Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Centessa Pharmaceuticals: Scholar Rock Holding Co. (18.66%), Ocugen, Inc. (18.04%), Repare Therapeutics Inc. (2.50%), Aclaris Therapeutics, Inc. (1.95%), Ventyx Biosciences, Inc. (15.32%), Seres Therapeutics, Inc. (10.61%), Agenus Inc. (14.71%), Viking Therapeutics, Inc. (12.91%), Elanco Animal Health Incorporated (2.33%), Blueprint Medicines Co. (5.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Centessa Pharmaceuticals stock? Short selling CNTA is an investing strategy that aims to generate trading profit from Centessa Pharmaceuticals as its price is falling. CNTA shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Centessa Pharmaceuticals? A short squeeze for Centessa Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNTA, which in turn drives the price of the stock up even further. How often is Centessa Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNTA, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies SRRK Short Interest Data OCGN Short Interest Data RPTX Short Interest Data ACRS Short Interest Data VTYX Short Interest Data MCRB Short Interest Data AGEN Short Interest Data VKTX Short Interest Data ELAN Short Interest Data BPMC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CNTA) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredJD Vance Exposes Wall Street’s Secret Plot Against TrumpTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredThe secret supplier behind NVIDIA, Tesla and MicrosoftThe Biggest AI firms in the world...Tesla... Microsoft... NVIDIA... Are all relying on a little-known suppl...Behind the Markets | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.